优化NIV Medicare准入:OSA患者的技术专家小组报告
本文汇总了美国胸科医师学会等四家学会关于OSA患者PAP治疗医保覆盖的技术专家小组建议。小组识别出症状清单不足、每晚4小时使用要求、重复睡眠检查及远程医疗限制等障碍,并基于证据提出放宽症状标准、降低使用时长至>2小时、免除再认证睡眠检查、允许远程医疗及家庭血氧等关键建议,以优化PAP治疗可及性。
要点
- 建议取消轻度OSA的症状标准以扩大PAP覆盖。
- 持续覆盖的PAP使用时长要求应降至每晚>2小时。
- 不依从或新CMS受益者无需睡眠检查再认证。
核心结论
- 为优化PAP治疗可及性,建议调整现行医保覆盖政策,包括取消轻度OSA症状标准、降低使用时长要求、免除再认证睡眠检查、允许远程医疗及家庭血氧评估。
研究设计与样本
- 技术专家小组报告,由美国胸科医师学会、美国呼吸治疗协会、美国睡眠医学会和美国胸科学会联合制定。
主要发现
- 当前覆盖障碍包括症状清单不足以涵盖轻度OSA所有潜在症状、每晚4小时PAP使用要求、再认证需额外睡眠检查、远程医疗随访不可用。
- 证据支持每晚2小时PAP使用可改善生活质量等指标。
- 对所有不依从患者或补充氧气进行额外睡眠检查的成本不合理,且远程医疗访视成功且被接受。
关键数值与推荐
- 建议取消轻度OSA的症状标准。
- 建议将持续覆盖标准降至每晚>2小时。
- 建议不依从或新CMS受益者已使用且依从PAP时免除再认证睡眠检查。
- 建议允许远程医疗访视记录获益和依从性。
- 建议允许PAP报告和家庭血氧用于需要时补充氧气的资格认定。
临床怎么用
- 临床中可依据建议放宽轻度OSA患者PAP覆盖,关注每晚>2小时使用即可获益,利用远程医疗和家庭血氧简化随访与氧气资格评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This document summarizes the work of the CPAP and bilevel PAP therapy for OSA Technical Expert Panel working group. For positive airway pressure (PAP) therapy, the most pressing current coverage barriers identified were: an insufficient symptom list describing all potential symptoms in patients with mild OSA; the 4 h per night of PAP usage requirement to keep the device; the additional sleep studies requirement to re-qualify for PAP or supplemental oxygen; and the inability to use telehealth visits for follow-up visits. Critical evidence supports changes to current policies and includes: symptom list inadequate to cover all scenarios based on updated clinical practice guidelines; published evidence that 2 h per night of PAP use can result in benefit to quality of life and other metrics; the costs of another sleep study not justified for all nonadherent patients or for supplemental oxygen due to other types of assessment currently available; and the remarkable success and acceptance of telehealth visits. To achieve optimal access for patients on PAP therapy, we make the following key suggestions: removing symptom criteria for mild OSA; reduce continued coverage criteria to > 2 h per night; eliminate the need for a sleep study to re-qualify if nonadherent or for new Centers for Medicare & Medicaid Services beneficiaries already on and adherent to PAP therapy; allow telehealth visits for documenting benefit and adherence; and allow PAP reports and domiciliary oximetry to qualify for supplemental oxygen with PAP if needed. This paper shares our best vision for bringing the right device to the right patient at the right time.
引用
- Patil SP, Collop NA, Chediak AD, et al. Optimal NIV Medicare Access Promotion: Patients With OSA: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society. Chest. 2021. PMID: 34339689. doi:10.1016/j.chest.2021.06.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。